CAS 154702-76-8 appears in our catalog under these names: Methyl brevifolincarboxylate, Methyl brevifolincarboxylate, Cyclopenta[c][2]benzopyran-1-carboxylic acid, 1,2,3,5-tetrahydro-7,8,9-trihydroxy-3,5-dioxo-, methyl ester, ≥98%. Offered by: GLPBio, MedChemExpress, Chemat. Available pack sizes: 1mg, 1 mg, 5 mg, 10 mg, 5mg.
Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, a radical scavenger, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a platelet aggregation inhibitor and an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor. It is a delta-lactone, an organic heterotricyclic compound, a member of phenols and a cyclic ketone.
Source: ChEBI
| Molecular formula | C14H10O8 |
|---|---|
| Molecular weight | 306.22 g/mol |
| IUPAC name | methyl 7,8,9-trihydroxy-3,5-dioxo-1,2-dihydrocyclopenta[c]isochromene-1-carboxylate |
| InChIKey | JNWDNAASYHRXMG-UHFFFAOYSA-N |
| SMILES | COC(=O)C1CC(=O)C2=C1C3=C(C(=C(C=C3C(=O)O2)O)O)O |
Computed by PubChem (NCBI)